Germany’s BioNTech, Pfizer’s partner in COVID-19 vaccines, said the two companies would start tests on humans of next-generation shots that protect against a wide variety of coronaviruses in the second half of the year.

French drugmaker Sanofi said on Wednesday uninsured diabetes patients in the United States will pay no more than $35 for a 30-day supply of insulin, in the wake of heightened public scrutiny over soaring prices of the life-saving drug.

FDA

The FDA’s Vaccines and Related Biological Products Advisory Committee voted 19-2 that the next wave of COVID booster shots should include a component that targets the Omicron variant of the coronavirus.

The European Commission proposed on Wednesday to ban the sale in the EU of flavored heated tobacco products after a big rise in their consumption.

Eli Lilly

As per the modified supply agreement with the government, Lilly will provide an additional 150,000 doses of bebtelovimab for about $275 million. The drug has also shown effectiveness against the Omicron variant.

The U.S. government is ramping up efforts to staunch the spread of monkeypox by sending hundreds of thousands of vaccine doses to states in the coming months, expanding access for those most at risk and increasing supply to areas with high case numbers.

The fast-spreading BA.4 and BA.5 sub-variants of Omicron are estimated to make up a combined 52% of the coronavirus cases in the United States as of June 25, the U.S. Centers for Disease Control and Prevention (CDC) said on Tuesday.

U.S. regulators plan to decide by early July on whether to change the design of COVID-19 vaccines this fall in order to combat more recent variants of the coronavirus, with hopes of launching a booster campaign by October, a top Food and Drug Administration official said on Tuesday.

The European Union’s drug regulator said on Tuesday it has started a review to extend the use of Bavarian Nordic’s (BAVA.CO) smallpox vaccine to prevent monkeypox disease as well.

Oklahoma has reached a $250 million settlement with AmerisourceBergen Corp., Cardinal Health Inc., and McKesson Corp. to resolve allegations the drug distributors contributed to the opioid epidemic in the state, Oklahoma Attorney General John O’Connor said on Monday.